Company news: Merck’s (MRK) quarterly results top analysts’ estimates

Merck (MRK) reported Q1 FY2025 earnings of $2.22 per share (versus $2.07 per share in Q1 FY2024), beating analysts’ consensus estimate of $2.13 per share.

The company’s quarterly revenues amounted to $15.529 bln (-1.6% y/y), beating analysts’ consensus estimate of $15.350 bln.

The company also issued guidance for FY2025, seeing EPS of $8.82-8.97, up from its prior guidance of $8.88-9.03, versus analysts’ consensus estimate of $8.94 and revenues of $64.1-65.6 bln versus analysts’ consensus estimate of $64.97 bln.

MRK rose to $79.87 (+1.44%) in pre-market trading.